Patent ID: RE42132

Claim:
A 2-Substituted D-homoestra-1,3,5(10)-trien-3-yl sulfamate of formula I in which R 1 and R 2 are, independently of one another, a hydrogen atom, a methyl group, a C 1 -C 4 -acyl group or a benzoyl group, R 3 means a C 1 -C 5 -alkyl, a C 1 -C 5 -alkyloxy group or a radical —O—C n F m H o , wherein n=1, 2, 3, 4, 5 or 6, m>1, and m+o=2n+1, R 6 and R 7 , are, independently of one another, a hydrogen atom, a hydroxy group, an amino group or an NHR 8 group, wherein R 8 is an acetyl group, or R 6 and R 7 together are an oxime NOH, R 13 is a hydrogen atom or a methyl group, R 19 is a hydrogen atom or a fluorine atom, R 20 is a hydrogen atom or a fluorine atom or a hydroxy group or a C 1 -C 5 -alkyloxy group or C 1 -C 5 -alkyl group or a radical —C n F m H o , wherein n=1, 2, 3, 4, 5 or 6, m>1 and m+o=2n+1, or a group SO 2 NR 1 R 2 , or R 19 and R 20 together mean an oxygen atom, a methylene group, a difluoromethylene group or a monofluoromethylene group or an oxime NOR 21 , wherein R 21 is a hydrogen atom or a C 1 -C 5 -alkyl group, or a pharmaceutically acceptable salt thereof.